Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight The ARSD clinical trial analysis report delivers important ...
The use of Bubble Continuous Positive Airway Pressure (bCPAP) is expanding across hospitals in Bangladesh, with six ...
Ards brothers are looking to the future TUCKED away in the rolling landscape of Ards, a quiet transformation is taking shape.
The first phase of nationwide hands-on training on the use of bubble CPAP in treating respiratory distress caused by measles-induced pneumonia was launched today.
Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced that its chief ...
ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in US/EU C-Further Consortium collaboration adds to ...
CHICAGO -- Classifying inflammatory subphenotypes of acute respiratory distress syndrome (ARDS) with bedside lab testing was feasible and showed differences in 60-day mortality, according to a ...
The biggest stories of the day delivered to your inbox.
A continuous postoperative sivelestat infusion reduced ARDS rates versus placebo after cardiovascular surgery (16.8% vs 31.2%; P < .001). Ninety-day all-cause mortality was lower with sivelestat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results